Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ivette Orosa-Vázquez
affiliation not provided to SSRN
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
30
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial
Number of pages: 56
Posted: 01 Feb 2022
Maria Eugenia-Toledo-Romani
,
Mayra García Carmenate
,
Leslyhana Verdecia-Sánchez
,
Suzel Pérez-Rodríguez
,
Meiby Rodriguez-González
,
Carmen Valenzuela-Silva
,
Beatriz Paredes-Moreno
,
Belinda Sánchez-Ramírez
,
Raul González-Mugica
,
Tays Hernández-García
, Ivette Orosa-Vázquez,
Marianniz Díaz-Hernández
,
María Teresa Pérez-Guevara
,
Juliet Enríquez-Puertas
,
Enrique Noa-Romero
,
Ariel Palenzuela-Diaz
,
Gerardo Baro-Roman
,
Ivis Mendoza-Hernández
,
Yaima Muñoz
,
Yanet Gómez-Maceo
,
Bertha Leysi Santos Vega
,
Sonsire Fernandez-Castillo
,
Yanet Climent-Ruiz
,
Laura Rodríguez-Noda
,
Darielys Santana-Mederos
,
Yanelda García-Vega
,
Guang Wu-Chen
,
Delaram Doroud
,
Alireza Biglari
,
Tammy Boggiano-Ayo
,
Yury Valdés-Balbín
,
Daniel G. Rivera
,
Dagmar García-Rivera
,
Vicente Verez-Bencomo
and
SOBERANA Research Group
Instituto de Medicina Tropical Pedro Kouri, Havana Hygiene and Epidemiology Center,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Finlay Vaccine Institute,
affiliation not provided to SSRN
, Finlay Vaccine Institute, Center of Molecular Immunology, Finlay Vaccine Institute, Center of Molecular Immunology,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Civilian Defense Scientific Research Centre, Immunoassay Center,
affiliation not provided to SSRN
, National Coordinating Center for Clinical Trials,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Finlay Vaccine Institute, Finlay Vaccine Institute,
affiliation not provided to SSRN
, Finlay Vaccine Institute,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Pasteur Institute of Iran, Pasteur Institute of Iran,
affiliation not provided to SSRN
, Finlay Vaccine Institute,
affiliation not provided to SSRN
, Finlay Vaccine Institute, Finlay Vaccine Institute and Independent
Downloads
30
(1,318,317)
View PDF
Download
Abstract:
conjugate vaccine, heterologous schedule, COVID-19, recombinant RBD, phase IIb clinical trial
Feedback